Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Hirsch

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Scientific Reports|September 7, 2018
Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profilesChristiaan A Rees, Mavra Nasir, Agnieszka Smolinska, et al.
Journal of Global Antimicrobial Resistance|May 1, 2020
Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from U.S. medical centresElizabeth B Hirsch, Hunter V Brigman, Paola C Zucchi, et al.
Journal of the American Pharmacists Association : Japha|April 3, 2022
Brighter horizons: The necessity of concentrated sponsorship targeted toward minoritized student pharmacistsCaroline L Ko, Jacinda C Abdul-Mutakabbir, Kevin N Astle, et al.
Lancet Regional Health. Americas|May 23, 2022
A call to action: A need for initiatives that increase equitable access to COVID-19 therapeuticsJacinda C Abdul-Mutakabbir, Elizabeth B Hirsch, Caroline Ko, et al.
American Journal of Pharmaceutical Education|June 14, 2023
Academic Activism: An Avenue to ActionKevin N Astle, Vibhuti Arya, Hayley Blackburn, et al.
Jac-Antimicrobial Resistance|January 19, 2026
A full educational resource review of grey literature resources for vancomycin dosing tutorialsEmma S Kuska, Jen Mlyniec, Kathleen L Wantuch, et al.
Cell Reports. Medicine|April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomesYuting Shan, Yingbo Huang, Adam Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Patient PerspectivesBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTIBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTIBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Scientific Reports|September 7, 2018
Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profilesChristiaan A Rees, Mavra Nasir, Agnieszka Smolinska, et al.
Journal of Global Antimicrobial Resistance|May 1, 2020
Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from U.S. medical centresElizabeth B Hirsch, Hunter V Brigman, Paola C Zucchi, et al.
Journal of the American Pharmacists Association : Japha|April 3, 2022
Brighter horizons: The necessity of concentrated sponsorship targeted toward minoritized student pharmacistsCaroline L Ko, Jacinda C Abdul-Mutakabbir, Kevin N Astle, et al.
Lancet Regional Health. Americas|May 23, 2022
A call to action: A need for initiatives that increase equitable access to COVID-19 therapeuticsJacinda C Abdul-Mutakabbir, Elizabeth B Hirsch, Caroline Ko, et al.
American Journal of Pharmaceutical Education|June 14, 2023
Academic Activism: An Avenue to ActionKevin N Astle, Vibhuti Arya, Hayley Blackburn, et al.
Jac-Antimicrobial Resistance|January 19, 2026
A full educational resource review of grey literature resources for vancomycin dosing tutorialsEmma S Kuska, Jen Mlyniec, Kathleen L Wantuch, et al.
Cell Reports. Medicine|April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomesYuting Shan, Yingbo Huang, Adam Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Patient PerspectivesBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTIBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTIBarbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, et al.
Pageof 8